The case for uniform testing of HbA1c in insurance specimens

In the setting of a worldwide increase in obesity and diabetes, reviews the protective value of current testing strategies. In plausible scenarios, shows that choosing uniform testing with HbA1c produces mortality savings that recover testing costs within short durations.

https://www.heritagelabs.net/NewsletterPDF/HL_UniformTesting_HbA1c.pdf